Arkolith/Insider Trading/COLL/Form 4

Dreyer Scott

EVP & Chief Commercial OfficerCOLLEGIUM PHARMACEUTICAL, INC (COLL) · full profile →Form 4 · filed Aug 15, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$185K
Net Open-Market Flow
-$185K
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 13, 2025Option exercise(M)5K$21.34$104K108K
Aug 13, 2025Sell(S)5K$38.03$185K104K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 13, 2025Option exercise(M)5K—$016K

Transaction Codes

M
Option exercise / conversion
S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001062993-25-014526) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for COLLEGIUM PHARMACEUTICAL, INC

Build

Ask your agent about COLL insider filings

This filing is the Follow view. The Build view lets your agent pull every Form 4 for the issuer, the net open-market picture over 90 days, and the accession behind each row, through REST or MCP.

Get a key Compare plansForm 4 data
Copy-paste
curl -H "Authorization: Bearer YOUR_API_KEY" \
  "https://arkolith.com/api/v1/filing/0001062993-25-014526"
Ask your agent
Use Arkolith to summarize insider buying and selling at COLLEGIUM PHARMACEUTICAL, INC
over the last 90 days and cite the filings.